Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, <scp>placebo‐controlled</scp>, <scp>double‐blind</scp> study

Hiroshi Akasaka(Sapporo Medical University), Hiromi Rakugi(Osaka Rosai Hospital), Chikako Hara(Osaka Gakuin University), Yukiko Yasunobe(The University of Osaka), Tomohiro Minami(The University of Osaka), Masanobu Kanou(NOF Corporation (Japan)), Taku Fujimoto(The University of Osaka), Hironori Nakagami(Osaka Health Science University), Kento Asano(Osaka University Hospital), Kōichi Yamamoto(Osaka City General Hospital), Shin‐ichiro Imai(Washington University in St. Louis), Ken Sugimoto(Kawasaki Medical School), Kei Yamana(NOF Corporation (Japan)), Akihiko Shiraki(Osaka University Hospital), Kohji Nishida(The University of Osaka)
Geriatrics and gerontology international/Geriatrics & gerontology international
November 28, 2022
Cited by 33


Related Papers